Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
Boylan
Laura S
LS
D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D004345:Drug Industry; D016568:Drugs, Generic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D006293:Health Promotion; D006801:Humans; D000077213:Lamotrigine; D017060:Patient Satisfaction; D013810:Therapeutic Equivalency; D016896:Treatment Outcome; D014227:Triazines / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000927:Anticonvulsants; D016568:Drugs, Generic; D014227:Triazines; D000077213:Lamotrigine